<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7503976</article-id><article-id pub-id-type="doi">10.3390/molecules25173781</article-id><article-id pub-id-type="publisher-id">molecules-25-03781</article-id><article-categories><subj-group subj-group-type="heading"><subject>Communication</subject></subj-group></article-categories><title-group><article-title>In Vitro Studies on Antioxidant and Anti-Parasitic Activities of Compounds Isolated from <italic>Rauvolfia caffra</italic> Sond</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9957-7074</contrib-id><name><surname>Tlhapi</surname><given-names>Dorcas B.</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03781">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7868-3540</contrib-id><name><surname>Ramaite</surname><given-names>Isaiah D. I.</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03781">1</xref><xref rid="c1-molecules-25-03781" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Anokwuru</surname><given-names>Chinedu P.</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03781">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0126-6797</contrib-id><name><surname>van Ree</surname><given-names>Teunis</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03781">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4409-1955</contrib-id><name><surname>Hoppe</surname><given-names>Heinrich C.</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03781">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Makris</surname><given-names>Dimitris P.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-03781"><label>1</label>Department of Chemistry, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa; <email>dorcastlhapi@gmail.com</email> (D.B.T.); <email>anokwuruchi@gmail.com</email> (C.P.A.); <email>Teuns.VanRee@univen.ac.za</email> (T.v.R.)</aff><aff id="af2-molecules-25-03781"><label>2</label>Department of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa; <email>H.Hoppe@ru.ac.za</email></aff><author-notes><corresp id="c1-molecules-25-03781"><label>*</label>Correspondence: <email>Isaiah.Ramaite@univen.ac.za</email>; Tel.: +27-(0)1-5962-8262</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>25</volume><issue>17</issue><elocation-id>3781</elocation-id><history><date date-type="received"><day>27</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>As part of an ongoing study of natural products from local medicinal plants, the methanol extract of stem bark of <italic>Rauvolfia caffra</italic> Sond was investigated for biological activity. Column chromatography and preparative thin-layer chromatography were used to isolate lupeol (<bold>1</bold>), raucaffricine (<bold>2</bold>), <italic>N</italic>-methylsarpagine (<bold>3</bold>), and spegatrine (<bold>4</bold>). The crude extract, fractions and isolated compounds were tested for anti-oxidant, antitrypanosomal and anti-proliferation activities. Two fractions displayed high DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging activity and reducing power with IC<sub>50</sub> (The half maximal inhibitory concentration) and IC<sub>0.5</sub> values of 0.022 &#x000b1; 0.003 mg/mL and 0.036 &#x000b1; 0.007 mg/mL, and 0.518 &#x000b1; 0.044 mg/mL and 1.076 &#x000b1; 0.136 mg/mL, respectively. Spegatrine (<bold>4</bold>) was identified as the main antioxidant compound in <italic>R. caffra</italic> with IC<sub>50</sub> and IC<sub>0.5</sub> values of 0.119 &#x000b1; 0.067 mg/mL and 0.712 &#x000b1; 0 mg/mL, respectively. One fraction displayed high antitrypanosomal activity with an IC<sub>50</sub> value of 18.50 &#x003bc;g/mL. However, the major constituent of this fraction, raucaffricine (<bold>2</bold>), was not active. The crude extract, fractions and pure compounds did not display any cytotoxic effect at a concentration of 50 &#x003bc;g/mL against HeLa cells. This study shows directions for further in vitro studies on the antioxidant and antitrypanosomal activities of <italic>Rauvolfia caffra</italic> Sond.</p></abstract><kwd-group><kwd>bioactive compounds</kwd><kwd><italic>Rauvolfia caffra</italic> Sond</kwd><kwd>antioxidant activity</kwd><kwd>antitrypanosomal activity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-03781"><title>1. Introduction</title><p>Trypanosomiasis is a fatal disease caused by the genus <italic>Trypanosoma</italic>, affecting humans and animals in many African countries [<xref rid="B1-molecules-25-03781" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-03781" ref-type="bibr">2</xref>,<xref rid="B3-molecules-25-03781" ref-type="bibr">3</xref>]. The protozoan parasites are transmitted by the bite of infected flies of the Tabanidae family [<xref rid="B4-molecules-25-03781" ref-type="bibr">4</xref>,<xref rid="B5-molecules-25-03781" ref-type="bibr">5</xref>]. The World Health Organization (WHO) estimates that over 70 million people in Sub-Saharan Africa are exposed to the risk of contracting this disease, which is deadly if left untreated [<xref rid="B6-molecules-25-03781" ref-type="bibr">6</xref>]. Treatment of this condition has been a challenge [<xref rid="B7-molecules-25-03781" ref-type="bibr">7</xref>], although the recent introduction of fexinidazole promises to alleviate some of the efficacy, toxicity and administration problems experienced with historical drug treatments [<xref rid="B8-molecules-25-03781" ref-type="bibr">8</xref>]. Nonetheless, the propensity of pathogens to generate resistance motivates the ongoing search for novel therapeutic drugs to combat this dreadful pathogen. Natural products from medicinal plants have played a vital role in the treatment of trypanosomiasis in various African countries [<xref rid="B2-molecules-25-03781" ref-type="bibr">2</xref>]. Therefore, medicinal plants have a great potential to provide new antiprotozoal treatments.</p><p>Oxidative stress is an imbalance between free radicals and antioxidants in the body, causing DNA damage, protein oxidation, lipid peroxidation, regulation of intracellular signal transduction and physiological adaptation phenomena [<xref rid="B9-molecules-25-03781" ref-type="bibr">9</xref>,<xref rid="B10-molecules-25-03781" ref-type="bibr">10</xref>]. Free radicals are unstable molecules that initiate mitochondrial oxidative phosphorylation, prostaglandin synthesis and phagocytosis [<xref rid="B11-molecules-25-03781" ref-type="bibr">11</xref>]. The human body is always at risk of being exposed to external sources of free radicals that could affect the functioning of the cells, but the body has developed a natural antioxidant defence system to prevent oxidative stress damage [<xref rid="B10-molecules-25-03781" ref-type="bibr">10</xref>]. Traditional medicinal plants have always been considered as a source of natural antioxidants [<xref rid="B12-molecules-25-03781" ref-type="bibr">12</xref>], which are highly effective in preventing the processes of oxidation by neutralizing free radicals [<xref rid="B13-molecules-25-03781" ref-type="bibr">13</xref>]. Numerous medicinal plants are used as alternative drugs and sources of novel plant-derived constituents that could be leads for treatments against numerous ailments [<xref rid="B14-molecules-25-03781" ref-type="bibr">14</xref>]. However, many compounds extracted from traditional plants have not been thoroughly studied for toxicity.</p><p>In our continuing search for biologically active metabolites of traditional medicinal plants from the Venda area in South Africa, we investigated <italic>Rauvolfia caffra</italic>, which is widely used in medicine in Sub-Sahara African communities to treat a range of ailments such as toothaches, hysteria, epilepsy, eye diseases, skin wounds, urticaria, severe abdominal pains, diarrhoea, headaches, constipation, irregular periods, swollen legs, palpitation of the heart, insomnia, insecurity, restlessness, anxiety and earache [<xref rid="B15-molecules-25-03781" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-03781" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-03781" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-03781" ref-type="bibr">18</xref>,<xref rid="B19-molecules-25-03781" ref-type="bibr">19</xref>,<xref rid="B20-molecules-25-03781" ref-type="bibr">20</xref>]. Previously, we isolated three indole alkaloids (raucaffricine, <italic>N</italic>-methylsarpagine and spegatrine) and one terpenoid (lupeol) from the stem bark of <italic>Rauvolfia caffra</italic> and found that the major constituents do not contribute to the antiplasmodial activity of <italic>R. caffra</italic> [<xref rid="B21-molecules-25-03781" ref-type="bibr">21</xref>].</p><p>The main constituents isolated and identified from the stem bark of <italic>R. caffra</italic> are macrocaffrine, yohimbine, sarpagan, akuammicine, dihydroindole, indolenine, peraksine, oxindole, anhydronium, ajmaline, ajmalicine and geissoschizol. These alkaloids also have pharmacological activities, such as antimicrobial, anti-inflammatory, antimalarial, antioxidant, antitumor and antidiabetic properties [<xref rid="B22-molecules-25-03781" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-03781" ref-type="bibr">23</xref>]. Although herbal practitioners use <italic>Rauvolfia caffra</italic> in South Africa and some African countries for the treatment of a wide range of diseases, there are a limited number of studies into the chemistry of the underground and aerial parts of <italic>R. caffra</italic> as well as the bioactivity of the extracts. Therefore, we decided to isolate compounds from the stem bark, identify the major chemical constituents present and determine if they are responsible for the bioactivity of the plant. Our results confirm the reported antioxidant activity of the crude methanol extracts from <italic>Rauvolfia caffra</italic> [<xref rid="B22-molecules-25-03781" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-03781" ref-type="bibr">23</xref>]. However, isolated compounds from this plant have not yet been studied for their antioxidant activity. Moreover, the antitrypanosomal activity of the crude methanol extracts and isolated bioactive compounds from <italic>Rauvolfia caffra</italic> have never been evaluated. Therefore, this study is the first survey to detect significant in vitro antioxidant and antitrypanosomal activities of <italic>R. caffra</italic>.</p></sec><sec sec-type="results" id="sec2-molecules-25-03781"><title>2. Results and Discussion</title><sec id="sec2dot1-molecules-25-03781"><title>2.1. Antioxidant Activity</title><p>In the DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging activity test, fraction F<sub>4</sub> exhibited the highest free radical scavenging activity with an IC<sub>50</sub> (50% inhibitory concentration) value of 0.022 &#x000b1; 0.003 mg/mL while Fraction F<sub>3</sub> displayed the lowest free radical scavenging activity with an IC<sub>50</sub> value of 1.143 &#x000b1; 0.478 mg/mL, as shown in <xref rid="molecules-25-03781-t001" ref-type="table">Table 1</xref>. In the ferric reducing power assay, fraction F<sub>3</sub> displayed the lowest reducing power activity with an IC<sub>0.5</sub> value of 2.151 &#x000b1; 0.372 mg/mL while fraction F<sub>4</sub> exhibited the highest reducing power activity with an IC<sub>0.5</sub> value of 0.518 &#x000b1; 0.044 mg/mL. Therefore, fraction F<sub>4</sub> exhibited the highest antioxidant activity in the DPPH free radical scavenging assay and reducing power assay. According to a literature survey, the biological activities of raucaffricine and <italic>N</italic>-methylsarpagine, which were isolated from fractions F<sub>3</sub> and F<sub>4</sub>, respectively, have never been evaluated. In our study the antioxidant activities of raucaffricine and <italic>N</italic>-methylsarpagine could not be tested due to insufficient amounts of material after chemical analysis. However, spegatrine (<bold>4</bold>), the main constituent of fraction F<sub>5</sub>, exhibited antioxidant activity; this is the first time that this activity is being reported for spegatrine. Lupeol (<bold>1</bold>), the main constituent of fraction F<sub>1</sub>, is a known anti-oxidant [<xref rid="B24-molecules-25-03781" ref-type="bibr">24</xref>], explaining the antioxidant activity of fraction F<sub>1</sub>.</p></sec><sec id="sec2dot2-molecules-25-03781"><title>2.2. Antitrypanosomal Activity</title><p>The antitrypanosomal activity of the crude extract, fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub>, F<sub>5</sub>, raucaffricine (<bold>2</bold>) and spegatrine (<bold>4</bold>) was determined against <italic>Trypanosoma brucei brucei</italic> (427 strain) parasites in in vitro cultures. The crude extract, fractions F<sub>1</sub> and F<sub>3</sub> strongly affected the viability of the trypanosomes at the tested concentration (50 &#x003bc;g/mL), with viabilities of &#x02212;0.1 &#x000b1; 0.2%, 11.3 &#x000b1; 2.7% and 1.0 &#x000b1; 0.1%, respectively, as shown in <xref ref-type="fig" rid="molecules-25-03781-f001">Figure 1</xref>. In contrast, at the same concentration, raucaffricine (<bold>2</bold>), isolated from F<sub>3</sub> did not decrease the viability of the trypanosomes (106.7 &#x000b1; 1.8%, <xref ref-type="fig" rid="molecules-25-03781-f001">Figure 1</xref>), showing that the major compound of this fraction did not contribute to the antitrypanosomal activity of the plant. To our knowledge this is the first report of significant antitrypanosomal activity of <italic>R. caffra</italic>.</p><p>As shown in <xref ref-type="fig" rid="molecules-25-03781-f002">Figure 2</xref>, the crude extract, fractions F<sub>1</sub> and F<sub>3</sub> displayed the highest antiparasitic activity with IC<sub>50</sub> values of 14.2 &#x003bc;g/mL, 18.5 &#x003bc;g/mL, and 15.6 &#x003bc;g/mL, respectively. The pentamidine used as reference had an IC<sub>50</sub> value of 0.003 &#x003bc;M. The antiprotozoal potential of lupeol (<bold>1</bold>), the main compound from fraction F<sub>1</sub>, has been reported before [<xref rid="B25-molecules-25-03781" ref-type="bibr">25</xref>].</p></sec><sec id="sec2dot3-molecules-25-03781"><title>2.3. Anti-Proliferation Activity</title><p>The cell toxicity assay (CTA) was used to determine the cytotoxic abilities of the crude extract, fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub>, raucaffricine (<bold>2</bold>) and spegatrine (<bold>4</bold>) against HeLa (human cervix adenocarcinoma) cells. Briefly, HeLa cells were cultured with the respective samples for 48 h and the remaining percentage cell viability relative to untreated control cells determined using resazurin. The standard drug emetine displayed an IC<sub>50</sub> value of 0.026 &#x003bc;M, whereas all the tested samples did not cause any cytotoxic effects at a concentration of 50 &#x003bc;g/mL, as shown in <xref ref-type="fig" rid="molecules-25-03781-f003">Figure 3</xref>. A previous study showed that <italic>R. caffra</italic> has anti-proliferation activity. The MeOH/CH<sub>2</sub>Cl<sub>2</sub> stem bark extract exhibited activity against the proliferation of Vero cells. However, the MeOH/CH<sub>2</sub>Cl<sub>2</sub> stem bark extract did not show significant activity against proliferation of RD and Hep-G2 cells [<xref rid="B26-molecules-25-03781" ref-type="bibr">26</xref>]. The anti-proliferation activity of <italic>R. caffra</italic> may be due to its active constituents, and these effects may be further influenced by the type of extraction and solvent used.</p><p>In the literature, the anti-proliferation activity of isolated compounds from <italic>Rauvolfia caffra</italic> has not been determined using HeLa cells. Therefore, this study is the first survey that assesses the important anti-proliferation activity of <italic>R. caffra</italic> against these human cells.</p></sec></sec><sec id="sec3-molecules-25-03781"><title>3. Materials and Methods</title><sec id="sec3dot1-molecules-25-03781"><title>3.1. General Experimental Procedure</title><p>All chemicals used were analytical grade purchased from Sigma-Aldrich (Darmstadt, Germany). Silica gel (0.063&#x02013;0.2 mm) and Sephadex LH-20 (Sigma-Aldrich, Darmstadt, Germany) were used as stationary phases and solvent mixtures described below were used as mobile phase in the chromatographic separations. Thin layer chromatography plates packed with silica gel (normal or reversed phase), were used to locate major components of the fractions.</p><sec id="sec3dot1dot1-molecules-25-03781"><title>3.1.1. High-Resolution Mass Spectrometry</title><p>A Waters Synapt G2 Quadrupole time-of-flight (QTOF) mass spectrometer (MS) (Thermo Fisher Scientific, Waltham, MA, USA) connected to a Waters Acquity ultra-performance liquid chromatograph (UPLC) (Waters, Milford, MA, USA) was used for direct injection high-resolution mass spectrometric analysis. One &#x000b5;L of sample was injected into a stream of 60% acetonitrile and 40% dilute (0.1%) aqueous formic acid. This conveyed the sample directly to the QTOF mass spectrometer where data were acquired using both positive and negative electrospray ionisation. The following MS settings were used: cone voltage of 15 V, desolvation temperature of 275 &#x000b0;C, desolvation gas at 650 L/h, and the rest of the MS settings optimized for best resolution and sensitivity.</p></sec><sec id="sec3dot1dot2-molecules-25-03781"><title>3.1.2. Infrared Spectroscopy</title><p>Attenuated total reflection (ATR) infrared (IR) spectra were recorded on an Alpha Fourier transform infrared (FTIR) spectrometer (Bruker, F&#x000e4;llanden, Switzerland).</p></sec><sec id="sec3dot1dot3-molecules-25-03781"><title>3.1.3. Nuclear Magnetic Resonance (NMR) Spectroscopy</title><p><sup>1</sup>H- and <sup>13</sup>C-nuclear magnetic resonance (NMR) spectra were recorded at 400 MHz and 100 MHz, respectively, with an Avance 400 spectrometer (Bruker, F&#x000e4;llanden, Switzerland) using residual undeuterated solvent as the internal standard.</p></sec></sec><sec id="sec3dot2-molecules-25-03781"><title>3.2. Plant Collection and Preparation</title><p>The stem bark of <italic>R. caffra</italic> was collected at the University of Venda Campus, located at 22&#x000b0;58&#x02032;32&#x02033; South and 30&#x000b0;26&#x02032;40&#x02033; East in Thohoyandou, Limpopo Province, South Africa in January 2016. Botanical identification was provided by Prof. Tshisikhawe, a botanist in the Department of Botany at the University of Venda, and a voucher specimen (BD 001) was deposited. The plant samples were air-dried for two months and the dry samples were ground to fine powder using an industrial blender (NETZSCH, Selb, Germany).</p></sec><sec id="sec3dot3-molecules-25-03781"><title>3.3. Extraction of Plant Material</title><p>About 1.7 kg ground stems of <italic>Rauvolfia caffra</italic> were soaked with 2 L methanol for 48 h at room temperature. The methanol extract was filtered, and then concentrated using a rotary evaporator (B&#x000dc;CHI Labortechnik AG, Flawil, Switzerland) at 50 &#x000b0;C to obtain 49.2 g of dried extract. The crude methanol extract (49.2 g) was subjected to column chromatography over silica gel [<xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>].</p><p>The extract was eluted initially with hexane and the solvent polarity was increased gradually with ethyl acetate and finally methanol, yielding 17 fractions. Fractions with similar TLC (Thin-layer chromatography) profiles, i.e., containing the same compounds but in varying concentrations, were combined and concentrated to dryness on a rotary evaporator giving a total of 8 fractions coded as F<sub>A</sub>-F<sub>H</sub>. F<sub>A</sub> was obtained with hexane/ethyl acetate (70:30); F<sub>B</sub> and F<sub>C</sub> were obtained with hexane/ethyl acetate (30:70); F<sub>D</sub> was obtained with ethyl acetate (100%); F<sub>E</sub> and F<sub>F</sub> were obtained with ethyl acetate/methanol (70:30); and F<sub>G</sub> and F<sub>H</sub> were obtained with ethyl acetate/methanol (30:70). The collected fractions were monitored on TLC plates.</p></sec><sec id="sec3dot4-molecules-25-03781"><title>3.4. Isolation and Purification of Compounds</title><p>Fractions F<sub>B</sub>, F<sub>E</sub>, F<sub>F</sub> and F<sub>G</sub> were further fractionated using column chromatography since they contained a large amount of material compared to fractions F<sub>A</sub>, F<sub>C</sub>, F<sub>D</sub> and F<sub>H</sub>.</p><p>Fraction F<sub>B</sub> (1.42 g) was subjected to Sephadex LH-20 column chromatography; the column was eluted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (50:50) followed by an increasing gradient of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (up to 10:90) to obtain F<sub>1</sub> (1 g). Fraction F<sub>E</sub> (4 g) was subjected to silica gel column chromatography; the column was eluted using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (50:50) followed by an increasing gradient of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (up to 10:90) to obtain 2 subfractions, F<sub>2</sub> (1.51 g) and F<sub>3</sub> (1.55 g). Fraction F<sub>F</sub> (4 g) was also subjected to silica gel column chromatography and the column was eluted using <italic>n</italic>-C<sub>6</sub>H<sub>12</sub>/EtOAc (50:50) followed by an increasing gradient of <italic>n</italic>-C<sub>6</sub>H<sub>12</sub>/EtOAc (up to 30:70) to obtain 1 subfraction, F<sub>4</sub> (3 g). Fraction F<sub>G</sub> (5.6 g) was subjected to Sephadex LH-20 column chromatography; the column was eluted using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (50:50) followed by an increasing gradient of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (up to 10:90) to obtain F<sub>5</sub> (5 g). The collected fractions were monitored on TLC plates. The thin layer chromatograms were developed in a solvent system of ethyl acetate/methanol/water (EMW 81:11:8). A natural product staining solution (1 g methanolic diphenylboric acid, 100 mL methanol, 5 mL PEG 400 and 95 mL ethanol) was used to visualize compounds on a TLC plate.</p><p>Fraction F<sub>1</sub> (0.5 g) was subjected to preparative TLC (normal phase) to obtain compound <bold>1</bold> (0.230 g, <xref ref-type="fig" rid="molecules-25-03781-f004">Figure 4</xref>). Fraction F<sub>2</sub> (0.5 g) was also subjected to preparative TLC (reversed phase) to obtain fraction F<sub>2a</sub> (0.2102 g), an intractable mixture. Fraction F<sub>3</sub> (0.5 g) was further purified using semi-preparative HPLC to yield compound <bold>2</bold> (0.019 g). Fraction F<sub>4</sub> (0.5 g) was also subjected to preparative TLC (reversed phase) to obtain compound <bold>3</bold> (0.1238 g). F<sub>5</sub> (1 g) was further purified using semi-preparative HPLC to obtain compound <bold>4</bold> (0.086 g). Compounds <bold>1</bold> [<xref rid="B25-molecules-25-03781" ref-type="bibr">25</xref>], <bold>2</bold> [<xref rid="B28-molecules-25-03781" ref-type="bibr">28</xref>], <bold>3</bold> [<xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>], and <bold>4</bold> [<xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>] are known compounds.</p><sec id="sec3dot4dot1-molecules-25-03781"><title>3.4.1. Lupeol (<bold>1</bold>)</title><p>IR: 3000 cm<sup>&#x02212;1</sup> (O-H). <sup>1</sup>H-NMR (400 MHz, CD<sub>3</sub>OD): &#x003b4;<sub>H</sub> 4.7 (1H, s, 29a-H), 4.6 (1H, s, 29b-H), 3.18 (1H, m, 3-H), 2.38 (1H, m, 19-H), 1.91 (1H, m, 21-H), 1.70 (3H, s, 30-H), 1.60 (1H, m, 2-H), 1.39 (1H, m, 18-H), 1.30 (1H, m, 9-H), 1.04 (3H, s, <sub>C</sub> 26-H), 1.0 (3H, s, 23-H), 0.97 (3H, s, 27-H), 0.86 (3H, s, 25-H), 0.77 (3H, s, 24-H) ppm. <sup>13</sup>C-NMR (100 MHz, CD<sub>3</sub>OD): &#x003b4;<sub>C</sub> 150.95 (C-20), 108.54 (C-29), 78.27 (C-3), 55.48 (C-5), 50.64 (C-9), 49.16 (C-18), 42.17 (C-14), 40.53 (C-8), 38.67 (C-4), 38.54 (C-1), 38.17 (C-13), 37.00 (C-10), 36.91 (C-16), 34.21 (C-7), 30.43 (C-21), 29.52 (C-23), 29.27 (C-2), 27.19 (C-15), 25.54 (C-12), 22.79 (C-11), 20.70 (C-30), 18.17 (C-6), 18.03 (C-28), 15.32 (C-26), 14.69 (C-24), 13.67 (C-27) ppm (<xref ref-type="app" rid="app1-molecules-25-03781">Figures S1&#x02013;S6</xref> [<xref rid="B21-molecules-25-03781" ref-type="bibr">21</xref>,<xref rid="B25-molecules-25-03781" ref-type="bibr">25</xref>]).</p></sec><sec id="sec3dot4dot2-molecules-25-03781"><title>3.4.2. Raucaffricine (<bold>2</bold>)</title><p>IR: &#x003bd;<sub>O-H</sub> at 3421.5 cm<sup>&#x02212;1</sup> (O-H) and &#x003bd;<sub>C = O</sub> at 1662.0 cm<sup>&#x02212;1</sup> (C=O). <sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): &#x003b4;<sub>H</sub> 7.55 (1H, d, <italic>J</italic> = 7.6 Hz, 9-H), 7.49 (1H, d, <italic>J</italic> = 7.2 Hz, 12-H), 7.39 (1H, dd, <italic>J</italic> = 7.6 Hz and <italic>J</italic> = 7.6 Hz, 10-H), 7.23 (1H, dd, <italic>J</italic> = 7.2 Hz and <italic>J</italic> = 7.6 Hz, 11-H), 5.65 (1H, q, <italic>J</italic> = 6.8 Hz, 19-H), 5.17 (1H, s, 21-H), 5.03 (1H, d, <italic>J</italic> = 4.4 Hz, 1&#x02032;-H), 4.57 (1H, s, 17-H), 4.42 (2H, dd, <italic>J</italic> = 7.6 Hz and <italic>J</italic> = 8.8 Hz, 6&#x02032;-H), 3.9-3.6 (1H, m, 5&#x02032;-H), 3.18 (1H, dd, <italic>J</italic> = 5.6 Hz and <italic>J</italic> = 6 Hz, 5-H), 3.08 (1H, m, 15-H), 2.68 (1H, dd, <italic>J</italic> = 4.8 Hz and 4.4 Hz, 6-H&#x003b2;), 2.34 (1H, dd, <italic>J</italic> = 6 and <italic>J</italic> = 6.4 Hz, 16-H), 2.16 (3H, s, OCOCH<sub>3</sub>), 1.87 (1H, dd, <italic>J</italic> = 4 Hz and <italic>J</italic> = 12 Hz, 14-H<sub>&#x003b1;</sub>), 1.77 (1H, dd, <italic>J</italic> = 4.8 Hz and <italic>J</italic> = 4.8 Hz, 14-H<sub>&#x003b2;</sub>), 1.67 (3H, d, <italic>J</italic> = 11.6 Hz, 18-CH<sub>3</sub>), 1.45 (1H, d, <italic>J</italic> = 6.8 Hz, 6-H<sub>&#x003b1;</sub>) ppm. <sup>13</sup>C-NMR (100 MHz, DMSO-d<sub>6</sub>): &#x003b4; 184.42 (C-2), 170.13 (C-22), 156.86 (C-13), 137.94 (C-20), 137.09 (C-8), 127.06 (C-11), 125.81 (C-10), 124.29 (C-9), 122.76 (C-19), 120.85 (C-12), 99.32 (C-1&#x02032;), 88.22 (C-21), 77.48 (C-3&#x02032;,5&#x02032;), 77.21 (C-17), 74.26 (C-2&#x02032;), 70.58 (C-4&#x02032;), 65.19 (C-7), 61.56 (C-6&#x02032;), 55.24 (C-5), 50.45 (C-3), 48.49 (C-16), 37.32 (C-6), 27.47 (C-15), 24.67 (C-14), 21.32 (C-23), 13.28 (C-18) ppm. HRMS [M]<sup>+</sup>: <italic>m</italic>/<italic>z</italic> 513.2241; calcd. for C<sub>27</sub>H<sub>32</sub>N<sub>2</sub>O<sub>8</sub>: 513.2237 (<xref ref-type="app" rid="app1-molecules-25-03781">Figures S7&#x02013;S12</xref> [<xref rid="B21-molecules-25-03781" ref-type="bibr">21</xref>,<xref rid="B28-molecules-25-03781" ref-type="bibr">28</xref>]).</p></sec><sec id="sec3dot4dot3-molecules-25-03781"><title>3.4.3. <italic>N</italic>-Methylsarpagine (<bold>3</bold>)</title><p>IR: 3312.90 (O-H), 2942.44 (C-H) and 2831.65 cm<sup>&#x02212;1</sup> (C-H). <sup>1</sup>H-NMR (400 MHz, CD<sub>3</sub>OD): &#x003b4;<sub>H</sub> 7.11 (1H, d, <italic>J</italic> = 8.6 Hz, 12-H), 6.77 (1H, d, <italic>J</italic> = 2.0 Hz, 9-H), 6.68 (1H, dd, <italic>J</italic> = 8.9, 2.2 Hz, 11-H), 5.59 (1H, q, <italic>J</italic> = 6.8 Hz, 19-H), 4.41 (1H, d AB, <italic>J</italic> = 15.6 Hz, 21-H<sub>&#x003b1;</sub>), 4.16 (1H, d AB, <italic>J</italic> = 15.6 Hz, 21-H<sub>&#x003b2;</sub>), 3.48 (2H, d, <italic>J</italic> = 7.2 Hz, 17-H), 3.28 (3H, s, N-CH<sub>3</sub>), 3.15 (1H, dd, <italic>J</italic> = 12.4, 4.8 Hz, 6-H<sub>&#x003b2;</sub>), 3.0 (3H, s, N<sup>+</sup>-CH<sub>3</sub>), 2.95 (1H, dd, <italic>J</italic> = 2.0, 10.4 Hz, 15-H), 2.9 (1H, d, <italic>J</italic> = 15.2 Hz, 6-H<sub>&#x003b1;</sub>), 2.4 (1H, dd, <italic>J</italic> = 11.6, 10.8 Hz, 14-H<sub>&#x003b1;</sub>), 2.12-2.0 (2H, m, 16-H + 14-H<sub>&#x003b2;</sub>), 1.82 (s, OH), 1.63 (3H, d, <italic>J</italic> = 6.7 Hz, 18-H) ppm. <sup>13</sup>C-NMR (100 MHz, CD<sub>3</sub>OD): &#x003b4;<sub>C</sub> 150.91 (C-10), 132.10 (C-20), 131.68 (C-13), 127.67 (C-8), 126.83 (C-2), 120.72 (C-19), 112.34 (C-12), 111.75 (C-11), 102.14 (C-9), 99.77 (C-7), 65.45 (C-5), 64.39 (C-17), 62.40 (C-21), 61.07 (C-3), 43.63 (C-16), 32.01 (C-14), 26.01 (C-15), 23.87 (C-6), 11.57 (C-18) ppm (<xref ref-type="app" rid="app1-molecules-25-03781">Figures S13&#x02013;S16</xref> [<xref rid="B21-molecules-25-03781" ref-type="bibr">21</xref>,<xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>]).</p></sec><sec id="sec3dot4dot4-molecules-25-03781"><title>3.4.4. Spegatrine (<bold>4</bold>)</title><p>IR: 3352.1 cm<sup>&#x02212;1</sup> (O-H) and 1638.8 cm<sup>&#x02212;1</sup> (N-H). <sup>1</sup>H-NMR (400 MHz, CD<sub>3</sub>OD): &#x003b4;H 7.24 (1H, d, <italic>J</italic> = 8.8 Hz, 12-H), 6.90 (1H, d, <italic>J</italic> = 2.0 Hz, 9-H), 6.78 (1H, dd, <italic>J</italic> = 2.2, 8.8 Hz, 11-H), 5.68 (1H, q, <italic>J</italic> = 6.8 Hz, 19-H), 4.45 (1H, d AB, <italic>J</italic> = 15.6 Hz, 21-H<sub>&#x003b1;</sub>), 4.23 (1H, d AB, <italic>J</italic> = 15.6 Hz, 21-H<sub>&#x003b2;</sub>), 3.58 (2H, d, <italic>J</italic> = 7.6 Hz, 17-H), 3.27 (1H, dd, <italic>J</italic> = 12.4, 4.8 Hz, 6-H<sub>&#x003b2;</sub>), 3.15 (3H, s, N<sup>+</sup>-CH<sub>3</sub>), 3.12 (1H, dd, <italic>J</italic> = 2.0, 10.4 Hz, 15-H), 3.04 (1H, d, <italic>J</italic> = 17.2 Hz, 6-H<sub>&#x003b1;</sub>), 2.54 (1H, dd, <italic>J</italic> = 11.6, 10.8 Hz, 14-H<sub>&#x003b1;</sub>), 2.23-2.13 (2H, m, 16-H + 14-H<sub>&#x003b2;</sub>), 1.97 (s, OH), 1.74 (3H, d, <italic>J</italic> = 6.8 Hz, 18-H) ppm. <sup>13</sup>C-NMR (100 MHz, CD<sub>3</sub>OD): &#x003b4;<sub>C</sub> 150.93 (C-10), 132.10 (C-20), 131.66 (C-13), 127.68 (C-8), 126.83 (C-2), 120.71 (C-19), 112.35 (C-12), 111.73 (C-11), 102.13 (C-7), 99.77 (C-9), 65.46 (C-5), 64.38 (C-21), 62.40 (C-17), 61.08 (C-3), 46.67 (N<sup>+</sup>-CH3), 43.62 (C-16), 32.00 (C-14), 26.01 (C-15), 23.87 (C-6), 11.56 (C-18) ppm. HRMS [M]<sup>+</sup>: <italic>m</italic>/<italic>z</italic> 325.1912; calcd. for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup>: 325.1911 (<xref ref-type="app" rid="app1-molecules-25-03781">Figures S17&#x02013;S21</xref> [<xref rid="B21-molecules-25-03781" ref-type="bibr">21</xref>,<xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>]).</p></sec></sec><sec id="sec3dot5-molecules-25-03781"><title>3.5. Antioxidant Activities</title><p>The crude extract, fractions and pure compounds were evaluated for antioxidant activity. Initially, the crude extract and fractions were tested. Then the compounds isolated from the fractions were tested. The highest IC<sub>50</sub> or IC<sub>0.5</sub> values indicate the lowest antioxidant activity while the lowest IC<sub>50</sub> or IC<sub>0.5</sub> values imply the highest antioxidant activity.</p><sec id="sec3dot5dot1-molecules-25-03781"><title>3.5.1. Free Radical Scavenging Assay (DPPH)</title><p>The DPPH free radical scavenging ability of the crude extract and fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub> was determined according to the spectrophotometric method of Anokwuru et al. [<xref rid="B29-molecules-25-03781" ref-type="bibr">29</xref>]. A 125 mM DPPH/methanol solution was prepared by dissolving 10 mg DPPH in 200 mL methanol. The 96-well plates were filled with 100 &#x000b5;L distilled water per well. One hundred &#x000b5;L of the crude extract, fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub>, compound <bold>4</bold> and 100 &#x000b5;L methanol were added in triplicate into the first three wells followed by serial dilution. Two hundred &#x003bc;L 0.3 M DPPH/methanol was added to each well containing the mixtures. The 96-well plate was kept in the dark for 30 min and the absorbance was measured using a VersaMax<sup>TM</sup> tuneable microplate reader at 517 nm.</p><p>The percentage radical scavenging was calculated by the following formula:<disp-formula>% Free RSA = [(ADPPH &#x02212; Asample)/(ADPPH)] &#x000d7; 100<label>(1)</label></disp-formula></p></sec><sec id="sec3dot5dot2-molecules-25-03781"><title>3.5.2. Reducing Power</title><p>The reducing power was determined according to the method of Anokwuru et al. [<xref rid="B29-molecules-25-03781" ref-type="bibr">29</xref>]. A 0.2 M (pH 6.6) sodium phosphate buffer (50 &#x000b5;L) and 50 &#x000b5;L of the crude extract, fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub>, and compound <bold>4</bold> were added in triplicate in the first three wells of a 96-well plate, followed by serial dilution. Fifty &#x000b5;L of a 1% aqueous potassium hexacyanoferrate(III) [K<sub>3</sub>Fe(CN)<sub>6</sub>] solution was added to each well. The 96-well plates were placed in an incubator for 20 min at 50 &#x000b0;C. After incubation, 50 &#x000b5;L of 10% trichloroacetic acid solution was added to each well. Eighty &#x000b5;L of each mixture was transferred to another 96-well plate and 80 &#x000b5;L of distilled water, followed by 16 &#x000b5;L ferric chloride (0.1% <italic>w</italic>/<italic>v</italic>) was added. Absorbance was measured using a VersaMax&#x02122; tuneable microplate reader at 700 nm.</p></sec></sec><sec id="sec3dot6-molecules-25-03781"><title>3.6. Antitrypanosomal Activity</title><p>To assess trypanocidal activity, compounds were added to in vitro cultures of <italic>T. b. brucei</italic> (strain Lister 427) in 96-well plates (triplicate; 2.4 &#x000d7; 10<sup>4</sup> parasites/well) at a fixed concentration of 20 &#x000b5;M for pure compounds (<bold>2</bold> and <bold>4</bold>) or 25 &#x000b5;g/mL for the crude extract and fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub>. The culture medium consisted of Iscove&#x02019;s Modified Dulbecco&#x02019;s Medium containing 25 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (IMDM; Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (Biowest), penicillin/streptomycin (Lonza) and HMI-9 supplement (0.05 mM bathocuproine disulfonic acid, 1.5 mM cysteine, 1.25 mM pyruvic acid, 0.09 mM uracil, 0.09 mM cytosine, 0.16 mM thymidine, 0.014% 2-mercaptoethanol, 1 mM hypoxanthine; all reagents from Sigma-Aldrich) [<xref rid="B30-molecules-25-03781" ref-type="bibr">30</xref>]. After an incubation period of 24 h at 37 &#x000b0;C in a 5% CO<sub>2</sub> humidified incubator, resazurin (Sigma-Aldrich) was added to a final concentration of 0.05 mM and incubation continued for a further 24 h, after which conversion of resazurin to resorufin was measured in a Spectramax M3 fluorescence plate reader (Molecular Devices; Exc<sub>560</sub>/Em<sub>590</sub>). The % cell viability in wells containing test samples was calculated relative to untreated control wells using the fluorescence readings, after subtracting background fluorescence in wells without cells. For dose-response experiments, parasites were cultured in the presence of 3-fold serial dilutions of the test samples and % viability plotted against log (compound concentration) to obtain IC<sub>50</sub> values by non-linear regression (GraphPad Prism v.5.02). Pentamidine (an existing drug for treatment of trypanosomiasis) was used as the positive control.</p></sec><sec id="sec3dot7-molecules-25-03781"><title>3.7. Anti-Proliferation Activity</title><p>To assess cytotoxicity, the samples were incubated at a fixed concentration of 20 &#x003bc;M for pure compounds (<bold>2</bold> and <bold>4</bold>) and 50 &#x003bc;g/mL for crude extract and fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub> in 96-well plates seeded 24 h earlier with HeLa cells (Cellonex; 2 &#x000d7; 10<sup>4</sup> cells per well). Incubation was carried out for 48 h in a 37 &#x000b0;C 5% CO<sub>2</sub> humidified incubator. The culture medium consisted of Dulbecco&#x02032;s modified Eagle&#x02032;s medium (DMEM; Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (Biowest) and penicillin/streptomycin/amphotericin (Lonza). Resazurin (Sigma-Aldrich) was added to a final concentration of 0.05 mM and incubation continued for 2 h, after which fluorescence (Exc<sub>560</sub>/Em<sub>590</sub>) was measured in a Spectramax M3 plate reader (Molecular Devices) (San Jose, CA, USA) [<xref rid="B31-molecules-25-03781" ref-type="bibr">31</xref>]. Fluorescence values were converted to % cell viability relative to untreated control wells, after subtracting background readings obtained from wells without cells.</p></sec><sec id="sec3dot8-molecules-25-03781"><title>3.8. Statistical Analysis</title><p>The collected data were entered on an Excel spreadsheet and statistical analysis was undertaken using the SPSS package (Chicago, IL, USA). The absorbance and reduced concentrations were used to calculate the linear regression. One-way analysis of variance (ANOVA) was used to compare mean values of the crude extract, fractions F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub> and F<sub>5</sub>, and spegatrine (<bold>4</bold>) obtained in the antioxidant tests; <italic>p</italic> &#x0003c; 0.05 was considered statistically significant. For dose-response experiments, parasites were cultured in the presence of 3-fold serial dilutions of the test samples and % viability plotted against log (compound concentration) to obtain IC<sub>50</sub> values by non-linear regression (GraphPad Prism v.5.02). Pentamidine (an existing drug for treatment of trypanosomiasis) was used as the positive control.</p></sec></sec><sec sec-type="conclusions" id="sec4-molecules-25-03781"><title>4. Conclusions</title><p>The main objective of this study was to determine the in vitro antioxidant, antitrypanosomal and anti-proliferation activities of <italic>R. caffra.</italic> The proven antioxidant and antiparasitic activities of the plant extract and its fractions, and their non-cytotoxicity, support the traditional medicinal use of <italic>R. caffra</italic> and also shows that traditional medicine is a reliable source of knowledge for the development of new drugs. The study also shows that the major constituent raucaffricine (<bold>2</bold>) does not contribute to the biological activities evaluated. Further research should be carried out to isolate, identify, characterize and elucidate the structures of more of the bioactive compounds present so as to have a complete picture in terms of its in vitro antioxidant and antitrypanosomal activities.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was financially supported by the National Research Foundation, Sasol Inzalo and University of Venda RPC. The parasite and cytotoxicity assays were supported by the SA Medical Research Council.</p></ack><fn-group><fn><p><bold>Sample Availability:</bold> Not available.</p></fn></fn-group><app-group><app id="app1-molecules-25-03781"><title>Supplementary Materials</title><p>Supplementary materials are available online.</p><supplementary-material content-type="local-data" id="molecules-25-03781-s001"><media xlink:href="molecules-25-03781-s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, D.B.T., I.D.I.R., C.P.A. and T.v.R.; methodology, D.B.T. and H.C.H.; formal analysis, D.B.T., I.D.I.R., C.P.A., T.v.R. and H.C.H.; data curation, D.B.T., I.D.I.R., C.P.A., T.v.R. and H.C.H.; writing&#x02014;original draft preparation, D.B.T., I.D.I.R., C.P.A., T.v.R. and H.C.H.; writing&#x02014;review and editing, D.B.T., I.D.I.R., C.P.A., T.v.R. and H.C.H. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-03781"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>S.</given-names></name><name><surname>Umar</surname><given-names>A.Z.</given-names></name><name><surname>Asmau</surname><given-names>M.</given-names></name><name><surname>Deepa</surname><given-names>S.</given-names></name><name><surname>Milli</surname><given-names>J.</given-names></name><name><surname>Fatima</surname><given-names>H.</given-names></name></person-group><article-title>In vitro antitrypanosomal activity of <italic>Breonadia salicina</italic> on <italic>Trypanasoma brucei brucei</italic></article-title><source>Inter. J. Pharm. Sci. Res.</source><year>2018</year><volume>9</volume><fpage>975</fpage><lpage>9492</lpage></element-citation></ref><ref id="B2-molecules-25-03781"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swallow</surname><given-names>B.M.</given-names></name></person-group><article-title>Impacts of trypanosomiasis on African agriculture</article-title><source>PAAT Tech. Sci. Ser.</source><year>2000</year><volume>2</volume><fpage>1</fpage><lpage>52</lpage></element-citation></ref><ref id="B3-molecules-25-03781"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patrick</surname><given-names>M.</given-names></name><name><surname>Epco</surname><given-names>H.</given-names></name><name><surname>Veerle</surname><given-names>L.</given-names></name><name><surname>Victor</surname><given-names>K.</given-names></name><name><surname>Jean-Jacques</surname><given-names>M.</given-names></name><name><surname>Pascal</surname><given-names>L.</given-names></name><name><surname>Marleen</surname><given-names>B.</given-names></name></person-group><article-title>Human African trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review</article-title><source>PLoS Negl. Trop. Dis.</source><year>2012</year><volume>6</volume><elocation-id>1919</elocation-id></element-citation></ref><ref id="B4-molecules-25-03781"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asres</surname><given-names>K.</given-names></name><name><surname>Bucar</surname><given-names>F.</given-names></name><name><surname>Knauder</surname><given-names>E.</given-names></name><name><surname>Yardley</surname><given-names>V.</given-names></name><name><surname>Kendrick</surname><given-names>H.</given-names></name><name><surname>Croft</surname><given-names>S.L.</given-names></name></person-group><article-title>In vitro Antiprotozoal Activity of Extract and compounds from the stem bark of Combretum molle</article-title><source>Phytother Res.</source><year>2001</year><volume>15</volume><fpage>613</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1002/ptr.897</pub-id><pub-id pub-id-type="pmid">11746844</pub-id></element-citation></ref><ref id="B5-molecules-25-03781"><label>5.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><article-title>Parasites&#x02014;African trypanosomiasis (also known as sleeping sickness)</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/parasites/sleepingsickness/index.html">https://www.cdc.gov/parasites/sleepingsickness/index.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-03-09">(accessed on 9 March 2020)</date-in-citation></element-citation></ref><ref id="B6-molecules-25-03781"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organisation</collab></person-group><source>World Health Statistics</source><publisher-name>World Health Organisation</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2015</year></element-citation></ref><ref id="B7-molecules-25-03781"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legros</surname><given-names>D.</given-names></name><name><surname>Ollivier</surname><given-names>G.</given-names></name><name><surname>Gastellu-Etchegorry</surname><given-names>M.</given-names></name></person-group><article-title>Treatment of Human African trypanosomiasis- present situation and needs for research and development</article-title><source>Lancet Infect. Dis.</source><year>2002</year><volume>20</volume><fpage>437</fpage><lpage>440</lpage></element-citation></ref><ref id="B8-molecules-25-03781"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deeks</surname><given-names>E.D.</given-names></name></person-group><article-title>Fexinidazole: First global approval</article-title><source>Drugs</source><year>2019</year><volume>79</volume><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">30635838</pub-id></element-citation></ref><ref id="B9-molecules-25-03781"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paliwal</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Pracheta</surname><given-names>S.S.</given-names></name><name><surname>Yadav</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group><article-title>Anti-nephrotoxic effect of administration of <italic>Moringa oleifera</italic> Lam in amelioration of DMBA-induced renal carcinogenesis in Swiss albino mice</article-title><source>Biol. Med.</source><year>2011</year><volume>3</volume><fpage>27</fpage><lpage>35</lpage></element-citation></ref><ref id="B10-molecules-25-03781"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrens</surname><given-names>J.F.</given-names></name></person-group><article-title>Mitochondrial formation of reactive oxygen species</article-title><source>J. Physiol.</source><year>2003</year><volume>552</volume><fpage>335</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">14561818</pub-id></element-citation></ref><ref id="B11-molecules-25-03781"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamid</surname><given-names>A.A.</given-names></name><name><surname>Aiyelaagbe</surname><given-names>O.</given-names></name><name><surname>Usman</surname><given-names>L.A.</given-names></name><name><surname>Ameen</surname><given-names>O.M.</given-names></name><name><surname>Lawal</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidants: Its medicinal and pharmacological applications</article-title><source>African J. Pure App. Chem.</source><year>2010</year><volume>4</volume><fpage>142</fpage><lpage>151</lpage></element-citation></ref><ref id="B12-molecules-25-03781"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>D.</given-names></name></person-group><article-title>Methods for determination of antioxidant capacity: A review</article-title><source>Int. J. Pharm. Sci. Res.</source><year>2015</year><volume>6</volume><fpage>546</fpage><lpage>566</lpage></element-citation></ref><ref id="B13-molecules-25-03781"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin</surname><given-names>G.</given-names></name><name><surname>Cakmak</surname><given-names>Y.S.</given-names></name><name><surname>Guler</surname><given-names>G.O.</given-names></name><name><surname>Aktumsek</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant properties of methanolic extract and fatty acid composition of <italic>Centaurea urvillei</italic> DC. subsp</article-title><source>hayekiana Wagenitz. Rec. Nat. Prod.</source><year>2011</year><volume>5</volume><fpage>123</fpage><lpage>132</lpage></element-citation></ref><ref id="B14-molecules-25-03781"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yen</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant effect of methanol extracts from lotus plumule and blossom (Nelumbo nucifera Gertn.)</article-title><source>J. Food Drug Anal.</source><year>2003</year><volume>11</volume><fpage>60</fpage><lpage>66</lpage></element-citation></ref><ref id="B15-molecules-25-03781"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tshikalange</surname><given-names>T.E.</given-names></name><name><surname>Meyer</surname><given-names>J.J.M.</given-names></name><name><surname>Hussein</surname><given-names>A.A.</given-names></name></person-group><article-title>Antimicrobial activity, toxicity and the Isolation of a bioactive compound from plants used to treat sexually transmitted diseases</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>96</volume><fpage>515</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">15619572</pub-id></element-citation></ref><ref id="B16-molecules-25-03781"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schmelzer</surname><given-names>G.H.</given-names></name><name><surname>Gumb-Fakin</surname><given-names>A.</given-names></name></person-group><source>Plant Resources of Tropical Africa: Medicinal Plants 1. Plants Resources of Tropical Africa, NO. 11(1)</source><publisher-name>PROTA Foundation</publisher-name><publisher-loc>Wageningen, The Netherlands</publisher-loc><year>2008</year></element-citation></ref><ref id="B17-molecules-25-03781"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>J.I.A.</given-names></name><name><surname>Mortensen</surname><given-names>A.</given-names></name><name><surname>M&#x000f8;lgaard</surname><given-names>P.</given-names></name></person-group><article-title>Tissue lipid lowering effect of traditional Nigerian antidiabetic infusion of <italic>Rauvolfia vomitoria</italic> foliage and <italic>Citrus aurantium</italic> fruit</article-title><source>J. Ethnopharm.</source><year>2006</year><volume>104</volume><fpage>379</fpage><lpage>386</lpage></element-citation></ref><ref id="B18-molecules-25-03781"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Njau</surname><given-names>E.A.</given-names></name></person-group><article-title>An ethnobotanical study of medicinal plants used by the Maasai People of Manyara, Arusha-Tanzania</article-title><source>M.Sc Thesis</source><publisher-name>Addis Ababa University</publisher-name><publisher-loc>Addis Ababa, Ethiopia</publisher-loc><year>2011</year></element-citation></ref><ref id="B19-molecules-25-03781"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesewu</surname><given-names>G.A.</given-names></name><name><surname>Cutler</surname><given-names>R.R.</given-names></name><name><surname>Humber</surname><given-names>D.P.</given-names></name></person-group><article-title>Antibacterial activity of plants used in traditional medicines of Ghana with particular reference to MRSA</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>116</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">18096337</pub-id></element-citation></ref><ref id="B20-molecules-25-03781"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Oyedeji</surname><given-names>L.</given-names></name></person-group><source>Drugless Healing Secrets</source><publisher-name>Panse Press</publisher-name><publisher-loc>Ibadan, Nigeria</publisher-loc><year>2007</year></element-citation></ref><ref id="B21-molecules-25-03781"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tlhapi</surname><given-names>D.B.</given-names></name><name><surname>Ramaite</surname><given-names>I.D.I.</given-names></name><name><surname>van Ree</surname><given-names>T.</given-names></name><name><surname>Anokwuru</surname><given-names>C.P.</given-names></name><name><surname>Orazio</surname><given-names>T.-S.</given-names></name><name><surname>Hoppe</surname><given-names>H.C.</given-names></name></person-group><article-title>Isolation, Chemical Profile and Antimalarial Activities of Bioactive Compounds from <italic>Rauvolfia caffra</italic> Sond</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>39</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24010039</pub-id></element-citation></ref><ref id="B22-molecules-25-03781"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erasto</surname><given-names>P.</given-names></name><name><surname>Labuschagne</surname><given-names>A.</given-names></name><name><surname>Mbwambo</surname><given-names>Z.H.</given-names></name><name><surname>Nondo</surname><given-names>R.S.</given-names></name><name><surname>Lall</surname><given-names>N.</given-names></name></person-group><article-title>Antimycobacterial, antioxidant activity and toxicity of extracts from the roots of <italic>Rauwolfia vomitoria</italic> and <italic>Rauwolfia caffra</italic></article-title><source>Spatula DD&#x02014;Peer Reviewed. J. Complem. Med. Drug Dis.</source><year>2011</year><volume>1</volume><fpage>73</fpage><lpage>80</lpage></element-citation></ref><ref id="B23-molecules-25-03781"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gbonjubola</surname><given-names>A.</given-names></name><name><surname>Samuel</surname><given-names>N.</given-names></name><name><surname>Josiah</surname><given-names>O.</given-names></name><name><surname>Joseph</surname><given-names>E.</given-names></name></person-group><article-title>Preliminary <italic>in-vitro</italic> antibacterial activities of ethanolic and aqueous extracts of <italic>Rauvolifia caffra</italic></article-title><source>Int. J. Pharm. Res. Dev.</source><year>2010</year><volume>2</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="B24-molecules-25-03781"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchimene</surname><given-names>M.K.</given-names></name><name><surname>Nwaehujor</surname><given-names>C.O.</given-names></name><name><surname>Ezenwali</surname><given-names>M.</given-names></name><name><surname>Okoli</surname><given-names>C.C.</given-names></name><name><surname>Iwu</surname><given-names>M.M.</given-names></name></person-group><article-title>Free Radical Scavenging Activity of Lupeol isolated from the methanol leaf extract of <italic>Crateva Adansonii</italic> Oliv</article-title><source>Intern. J. Pharmacog. Phytochem. Res.</source><year>2016</year><volume>28</volume><fpage>419</fpage><lpage>426</lpage></element-citation></ref><ref id="B25-molecules-25-03781"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddique</surname><given-names>H.F.</given-names></name><name><surname>Saleem</surname><given-names>M.</given-names></name></person-group><article-title>Beneficial health effects of lupeol triterpene: A review of preclinical studies</article-title><source>Life Science.</source><year>2011</year><volume>88</volume><fpage>285</fpage><lpage>329</lpage></element-citation></ref><ref id="B26-molecules-25-03781"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Milugo</surname><given-names>T.K.</given-names></name><name><surname>Omosa</surname><given-names>L.K.</given-names></name><name><surname>Ochanda</surname><given-names>J.O.</given-names></name><name><surname>Wamunyokoli</surname><given-names>F.A.</given-names></name><name><surname>Oyugi</surname><given-names>J.O.</given-names></name></person-group><article-title>Phytochemical composition, antioxidant and potential anti-cancer activity of extracts from Drumstick (<italic>Moringa oleifera</italic>) and Quinine tree (<italic>Rauwolfia caffra</italic>)</article-title><source>MSc Thesis</source><publisher-name>University of Nairobi</publisher-name><publisher-loc>Nairobi, Kenya</publisher-loc><year>2013</year></element-citation></ref><ref id="B27-molecules-25-03781"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Maryadele</surname><given-names>J.N.</given-names></name><name><surname>Neil</surname><given-names>P.</given-names></name></person-group><source>The Merck Index&#x02014;An Encyclopedia of Chemicals, Drugs, and Biologicals</source><publisher-name>Merck and Co. Inc.</publisher-name><publisher-loc>Whitehouse Station, NJ, USA</publisher-loc><year>2006</year></element-citation></ref><ref id="B28-molecules-25-03781"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;bel</surname><given-names>H.</given-names></name><name><surname>St&#x000f6;ckigt</surname><given-names>J.</given-names></name></person-group><article-title>RLCC-isolation of Raucaffricine from Its Most Efficient Source&#x02014;Cell Suspension Cultures of <italic>Rauwolfia Serpentina Benth</italic></article-title><source>Plant. Cell Rep.</source><year>1984</year><volume>3</volume><fpage>72</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">24253397</pub-id></element-citation></ref><ref id="B29-molecules-25-03781"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anokwuru</surname><given-names>C.P.</given-names></name><name><surname>Ramaite</surname><given-names>I.D.I.</given-names></name><name><surname>Bessong</surname><given-names>P.</given-names></name></person-group><article-title>Phenolic Content, Distribution and Antioxidant Activities of <italic>Terminalia sericea</italic> Burch</article-title><source>Afri. J. Tradit. Complement. Altern. Med.</source><year>2015</year><volume>12</volume><fpage>21</fpage><lpage>27</lpage></element-citation></ref><ref id="B30-molecules-25-03781"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scovill</surname><given-names>J.</given-names></name><name><surname>Blank</surname><given-names>E.</given-names></name><name><surname>Konnick</surname><given-names>M.</given-names></name><name><surname>Nenortas</surname><given-names>E.</given-names></name><name><surname>Shapiro</surname><given-names>T.</given-names></name></person-group><article-title>Antitrypanosomal activities of Tryptanthrins</article-title><source>Antimicrob. Agents. Chemother.</source><year>2002</year><volume>46</volume><fpage>882</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">11850279</pub-id></element-citation></ref><ref id="B31-molecules-25-03781"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stander</surname><given-names>A.</given-names></name><name><surname>Marais</surname><given-names>S.</given-names></name><name><surname>Stivaktas</surname><given-names>V.</given-names></name><name><surname>Vorster</surname><given-names>V.</given-names></name><name><surname>Albrecht</surname><given-names>C.</given-names></name><name><surname>Lottering</surname><given-names>M.-L.</given-names></name><name><surname>Joubert</surname><given-names>A.M.</given-names></name></person-group><article-title>In vitro effects of <italic>Sutherlandia frutescens</italic> water extracts on cell numbers, morphology, cell cycle progression and cell death in a tumorigenic and a non-tumorigenic epithelial breast cell line</article-title><source>J. Ethnopharm.</source><year>2009</year><volume>124</volume><fpage>45</fpage><lpage>60</lpage></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-03781-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Antiparasitic activity against <italic>T. brucei</italic>: Crude&#x02014;crude extract; F1&#x02014;Fraction F<sub>1</sub>; F2&#x02014;Fraction F<sub>2</sub>; F3&#x02014;Fraction F<sub>3</sub>; F4&#x02014;Fraction F<sub>4</sub>; F5&#x02014;Fraction F<sub>5</sub>; 2&#x02014;raucaffricine (<bold>2</bold>) and 4&#x02014;spegatrine (<bold>4</bold>) expressed as % parasite viability &#x000b1; standard deviation.</p></caption><graphic xlink:href="molecules-25-03781-g001"/></fig><fig id="molecules-25-03781-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Dose-response curves for the trypanosome assay: Extract&#x02014;crude extract; F3&#x02014;Fraction. F<sub>3</sub> and F1&#x02014;Fraction F<sub>1</sub> expressed as % parasite viability &#x000b1; standard deviation.</p></caption><graphic xlink:href="molecules-25-03781-g002"/></fig><fig id="molecules-25-03781-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Anti-proliferation activity against HeLa cells: Crude&#x02014;crude extract; F1&#x02014;Fraction F<sub>1</sub>; F2&#x02014;Fraction F<sub>2</sub>; F3&#x02014;Fraction F<sub>3</sub>; F4&#x02014;Fraction F<sub>4</sub>; F5&#x02014;Fraction F<sub>5</sub>; 2&#x02014;raucaffricine (<bold>2</bold>) and 4&#x02014;spegatrine (<bold>4</bold>) expressed as % HeLa cell viability &#x000b1; standard deviation.</p></caption><graphic xlink:href="molecules-25-03781-g003"/></fig><fig id="molecules-25-03781-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Compounds isolated from <italic>R. caffra</italic> extract: lupeol (<bold>1</bold>), raucaffricine (<bold>2</bold>), <italic>N</italic>-methylsarpagine (<bold>3</bold>) and spegatrine (<bold>4</bold>).</p></caption><graphic xlink:href="molecules-25-03781-g004"/></fig><table-wrap id="molecules-25-03781-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-03781-t001_Table 1</object-id><label>Table 1</label><caption><p>Antioxidant activity of crude extract, fractions and pure compound.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">DPPH IC<sub>50</sub> (mg/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reducing Power IC<sub>0.5</sub> (mg/mL)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Crude extract</td><td align="center" valign="middle" rowspan="1" colspan="1">0.213 &#x000b1; 0.068 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.226 &#x000b1; 0.443 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F<sub>1</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">0.653 &#x000b1; 0.307 <sup>a,b,c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.036 &#x000b1; 0.266 <sup>b,c</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">0.413 &#x000b1; 0.195 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.282 &#x000b1; 0.036 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">1.143 &#x000b1; 0.478 <sup>b,c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.151 &#x000b1; 0.372 <sup>b,c</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">0.022 &#x000b1; 0.003 <sup>a,d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.518 &#x000b1; 0.044 <sup>e</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">0.036 &#x000b1; 0.007 <sup>a,d,e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.076 &#x000b1; 0.136 <sup>a,e</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Spegatrine (<bold>4</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.119 &#x000b1; 0.067 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.715 &#x000b1; 0 <sup>a,e</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gallic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.045 &#x000b1; 0.018 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.115 &#x000b1; 0.007 <sup>e</sup></td></tr></tbody></table><table-wrap-foot><fn><p>Notes: A different superscript letter indicates significant difference using one-way ANOVA at <italic>p</italic> &#x0003c; 0.05. Data (<italic>n</italic> = 3) expressed as mean &#x000b1; standard deviation. For DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging activity: For DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging: <sup>a</sup>&#x02014;Crude extract was only significantly different from Fraction F<sub>3</sub>; <sup>a,b,c</sup>&#x02014;Fraction F<sub>1</sub> was significantly different from Fraction F<sub>4</sub> and Fraction F<sub>5</sub>, and <sup>a,d,e</sup>&#x02014;Fraction F<sub>4</sub> was not significantly different from Fraction F<sub>5</sub>. For Reducing power activity: <sup>b,c</sup>&#x02014;Fraction F<sub>1</sub> was not significantly different from Fraction F<sub>3</sub> and <sup>a,e</sup>&#x02014;Fraction F<sub>5</sub> was not significantly different from spegatrine (<bold>4</bold>).</p></fn></table-wrap-foot></table-wrap></floats-group></article>